comparemela.com
Home
Live Updates
Prnewswire Akebia Therapeutics Inc - Breaking News
Pages:
5
6
7
8
9
10
11
Latest Breaking News On - Prnewswire akebia therapeutics inc - Page 4 : comparemela.com
Akebia Therapeutics Announces Poster Presentations at National Kidney Foundation Spring Clinical Meetings 2023
/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.
United states
United kingdom
Akebia therapeutics inc
National kidney foundation
Prnewswire akebia therapeutics inc
Spring clinical meetings
Akebia therapeutics
Health care amp hospitals
Medical pharmaceuticals
Trade show news
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.
United kingdom
United states
Akebia therapeutics inc
Prnewswire akebia therapeutics inc
Nasdaq listing rule
Akebia therapeutics
Health care amp hospitals
Medical pharmaceuticals
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 4, 2023 /PRNewswire/ Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one. | June 21, 2023
United kingdom
United states
Mercedes carrasco
Prnewswire akebia therapeutics inc
Akebia therapeutics inc
Nasdaq listing rule
Akebia Therapeutics Files Revised Definitive Proxy Statement for Special Stockholder Meeting
/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.
United states
United kingdom
Johnp butler
Akebia therapeutics inc
Exchange commission
Prnewswire akebia therapeutics inc
European medicines agency
Special meeting
Nasdaq stock market
Chief executive officer
Exercising your vote
Vote processing
Akebia therapeutics
Securities litigation reform act
New drug application
Formal dispute resolution request
Akebia Therapeutics to Report Fourth Quarter and Full-Year 2022 Financial Results and Discuss Recent Business Highlights
/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.
United kingdom
United states
Akebia therapeutics inc
Prnewswire akebia therapeutics inc
Ghost conference
Registration link
Akebia therapeutics
vimarsana © 2020. All Rights Reserved.